Small Cap Press Flashback / Highlights 1/3/26
investorshangout.com/post/view?id...
#RDZN #SNYR #TOON #SJ #SURG #APRE
0
0
0
0
#APRE
Latest posts tagged with #APRE on Bluesky
Trending
Posts tagged #APRE
Eyes On These Trades Under $1 below:
thestreetreports.com/holiday-gift...
#TOON #BMXI #RNWF #PRSO #SJ #APRE
0
0
0
0
#Roads4All participated at the European Researchers' Night 2025 – 4Science at the CNR campus in Montelibretti (Italy).
#APRE brought the theme of #road #safety to an evening dedicated to discovery, play and encounters between #research and #society.
👉 More information: roads4all.eu/project-news/
0
0
0
0
Under $5 Small Cap December Press Flashback
investorshangout.com/post/view?id...
#SJ #APRE #RDZN #MYSE #SURG #SIGL #RNWF #AMLM
0
0
0
0
0
0
0
0
#APRE Aprea Therapeutics CEO Issues Letter to Shareholders Highlighting Pipeline Progress in 2025 and Outlook for 2026
www.globenewswire.com/news-release...
1
0
0
0
0
0
0
0
2
0
0
0
#APRE Aprea Therapeutics CEO Issues Letter to Shareholders Highlighting Pipeline Progress in 2025 and Outlook for 2026
www.stocktitan.net/news/APRE/aprea-therapeu...
0
0
0
0
#APRE Insider Trading Activity
Marc Duey, a director at Aprea Therapeutics bought 21,459 shares of the company on 12-10-2025 for an estimated $24,999.
www.quiverquant.com/news/Insider...
0
0
0
0
Sub-$1 stocks 7 major catalysts driving renewed attention.
thestreetreports.com/game-changin...
#BEAT #TOON #PRSO #APRE #PNPNF #SIGL
0
0
0
0
0
0
0
0
#APRE Aprea Therapeutics (NASDAQ: APRE) “The Street Reports Podcast”
thestreetreports.com/aprea-therap...
1
0
0
0
#APRE Financing from new and existing healthcare focused investors
The proceeds are expected to extend the Company’s cash runway into Q1 2027,
www.globenewswire.com/news-release...
0
0
0
0
#APRE Aprea Therapeutics Announces $3.1 Million Private Placement Priced At-The-Market Under Nasdaq Rules
www.stocktitan.net/news/APRE/aprea-therapeu...
0
0
0
0
#PNPNF #PNPN.V #TOON #PRSO #APRE
Traders seeking year-end catalysts, the $1-stock is once again in focus.
thestreetreports.com/1-stocks-to-...
0
0
0
0
0
0
0
0
Under $5 November Financials NYSE NASDAQ
investorshangout.com/post/view?id...
#PRSO #DVLT #SNYR #TOON #RDZN #APRE #TOMZ
0
0
0
0
#APRE Aprea is building next-generation cancer treatments. Strong third quarter results.
thestreetreports.com/aprea-nasdaq...
0
0
0
0
#APRE Maxim Group: Aprea Therapeutics NASDAQ: APRE Issued Buy Rating $10 Price
thestreetreports.com/wp-content/u...
0
0
0
0
#APRE Maxim Group: Issued A Buy Rating ($10 Price Target) Aprea Therapeutics
thestreetreports.com/wp-content/u...
0
0
0
0
0
0
0
0
#APRE Aprea Therapeutics Reports Third quarter 2025 Financial Results and Provides a Clinical Update
www.globenewswire.com/news-release...
1
0
0
0
#APRE Aprea Therapeutics Clinical Progress: Reported along with 3Q
www.globenewswire.com/news-release...
0
0
0
0
#APRE Aprea Therapeutics Reports Third quarter 2025 Financial Results and Provides a Clinical Update
www.stocktitan.net/news/APRE/aprea-therapeu...
0
0
0
0
#APRE Aprea Therapeutics Provides Clinical Update from ACESOT-1051 Trial
#SNYR Expands FOCUSfactor® with Kroger, PriceSmart & Wakefern
#TOON Kartoon Studios Capital infusion
#MYSE The Street Podcast Ready For Launch
#TOMZ Presentated at the LD Micro Main Event
#SmallCapBriefs #BioPharma #Retail
0
0
0
0
#APRE Aprea Therapeutics Provides Clinical Update from ACESOT-1051 Trial Showing Early Signals of Activity for WEE1 Kinase Inhibitor APR-1051
www.globenewswire.com/news-release...
0
0
0
0
#APRE Aprea Therapeutics Provides Clinical Update from ACESOT-1051 Trial Showing Early Signals of Activity for WEE1 Kinase Inhibitor APR-1051
www.stocktitan.net/news/APRE/aprea-therapeu...
0
0
0
0
#APRE Aprea Therapeutics, Phase 2 Dosing Update:
www.globenewswire.com/news-release...
#combinationtherapies.
0
0
0
0
#APRE Aprea Therapeutics Establishes Recommended Phase 2 Dose (RP2D) for ATRN-119, Considering Combination Therapies
www.globenewswire.com/news-release...
0
0
0
0